CAS 3999-01-7
:Linoleamid
- 9,12-Octadecadienamide, (9Z,12Z)-
- 9,12-Octadecadienamide, (9Z,12Z)-
- 9,12-Octadecadienamide, (Z,Z)-
- 9,12-Octadecadienamide
- (9Z,12Z)-octadeca-9,12-dienamide
- Linoleamide
- (9Z,12Z)-Octadeca-9,12-dien-1-amide
- Linoleic acid amide
- Linoleic acid amide
- (9Z,12Z)-9,12-Octadecadienamide
(9Z,12Z)-octadeca-9,12-dien-1-amide
CAS:Formel:C18H33NOReinheit:97%Farbe und Form:SolidMolekulargewicht:279.4607(9Z,12Z)-Octadeca-9,12-Dienamide
CAS:(9Z,12Z)-Octadeca-9,12-DienamideReinheit:99%Molekulargewicht:279.46g/molLinoleic Acid Amide
CAS:Linoleic Acid Amide (Linoleamide) is derived from linoleic acid and regulates Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase.
Formel:C18H33NOReinheit:98%Farbe und Form:SolidMolekulargewicht:279.469(Z),12(Z)-octadecadienamide
CAS:Formel:C18H33NOReinheit:>98%Farbe und Form:In solution, Methyl acetateMolekulargewicht:279.46(9Z,12Z)-Octadeca-9,12-dienamide
CAS:(9Z,12Z)-Octadeca-9,12-dienamide is a lipid molecule that is structurally similar to linoleamide. It has been shown to inhibit cholesterol synthesis in vitro and in vivo by competitively inhibiting the enzyme cholesterol esterase. This inhibition leads to a decrease in intracellular levels of free cholesterol and an increase in intracellular levels of free fatty acids. (9Z,12Z)-Octadeca-9,12-dienamide also inhibits the uptake of low density lipoproteins by macrophages and reduces the development of atherosclerosis. This compound is insoluble at physiological pH and therefore cannot be administered orally. However, it can be delivered via injection or intravenously as a lipid particle complex with cyclodextrin.
Formel:C18H33NOReinheit:Min. 95%Molekulargewicht:279.5 g/molRef: 3D-DAA99901
Ausgelaufenes produkt




